Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 1, 2013 - Issue 10
Submit an article Journal homepage
143
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Tafamidis for the treatment of transthyretin-associated familial amyloid polyneuropathy

Hartmut H-J SchmidtUniversitätsklinikum Münster, Klinik für Transplantationsmedizin, Münster, 48149, [email protected]
Pages 837-845 | Published online: 01 Oct 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Arianna Burton, Adam Castaño, Marianna Bruno, Steve Riley, Jennifer Schumacher, Marla B Sultan, Sandi See Tai, Daniel P Judge, Jignesh K Patel & Jeffery W Kelly. (2021) Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story. Drug Design, Development and Therapy 15, pages 1225-1243.
Read now

Articles from other publishers (4)

Darae Kim, Jin-Oh Choi & Eun-Seok Jeon. (2021) Tafamidis for Cardiac Transthyretin Amyloidosis. Cardiovascular Prevention and Pharmacotherapy 3:1, pages 1.
Crossref
Peter A. Lockwood, Vu H. Le, Melissa T. O'Gorman, Terrell A. Patterson, Marla B. Sultan, Ekaterina Tankisheva, Qiang Wang & Steve Riley. (2020) The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers. Clinical Pharmacology in Drug Development 9:7, pages 849-854.
Crossref
Fredrick Nwude Eze, Ladda Leelawatwattana & Porntip Prapunpoj. (2019) Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis. Biomolecules 9:4, pages 128.
Crossref
Teresa Coelho, Giampaolo Merlini, Christine E. Bulawa, James A. Fleming, Daniel P. Judge, Jeffery W. Kelly, Mathew S. Maurer, Violaine Planté-Bordeneuve, Richard Labaudinière, Rajiv Mundayat, Steve Riley, Ilise Lombardo & Pedro Huertas. (2016) Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis. Neurology and Therapy 5:1, pages 1-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.